VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
HQYHealthEquity, Inc.
$84.61$7.1B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHQYEarnings History

HQY logoHealthEquity, Inc. (HQY) Earnings History

Elite Compounder

14 years of earnings data (2013–2026) · 5-year EPS CAGR exceeds 18% — top-tier earnings quality

TTM Net Income
$231M
● Profitable
TTM EPS (Diluted)
$2.71
Per share, diluted
YoY EPS Growth
+125.7%
Excellent
Net Margin
16.4%
After-tax profitability
EPS Growth Rate (CAGR)
1Y+125.7%
3YN/A
5Y+83.0%
10Y+24.3%
Operating Margin24.6%
Gross Margin69.5%
Return on Equity10.2%
Return on Assets6.3%
Record Annual Net Income$215MFY2026
Record Quarterly EPS$0.82Q1 2027
Consecutive Profitable Years3years
Q1 2027
Net Income$69M
EPS (Diluted)$0.82
YoY Growth+125.7%Excellent
QoQ Growth+39.6%Excellent

Loading earnings history...

HealthEquity, Inc. (HQY) Earnings Overview

As of June 22, 2026, HealthEquity, Inc. (HQY) reported trailing twelve-month net income of $231M, reflecting +125.7% year-over-year growth. The company earned $2.71 per diluted share over the past four quarters, with a net profit margin of 16.4%.

Looking at the long-term picture, HQY's 5-year EPS compound annual growth rate (CAGR) stands at +83.0%, indicating exceptional earnings growth. The company achieved its highest annual net income of $215M in fiscal 2026, representing a new all-time high.

HealthEquity, Inc. maintains industry-leading profitability with a gross margin of 69.5%, operating margin of 24.6%, and net margin of 16.4%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →

Compared to peers including WEX ($310M net income, 11.4% margin), BEN ($812M net income, 6.0% margin), INVA ($504M net income, 63.8% margin), HQY has outperformed on profitability metrics. Compare HQY vs WEX →

HQY Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
HQY logoHQYCurrent
$231M$2.7116.4%10.2%+125.7%—
WEX logoWEX
$310M$8.8711.4%22.3%+12.9%
BEN logoBEN
$812M$1.576.0%3.7%+7.1%
INVA logoINVA
$504M$5.9463.8%29.1%+816.7%
GWRE logoGWRE
$160M$1.865.8%5.0%+1191.6%
PCTY logoPCTY
$258M$4.6914.2%20.0%+10.7%
Best in group
Lowest in group

HQY Historical Earnings Data (2013–2026)

14 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2026$215M+122.5%$322M$2.4616.4%24.6%
2025$97M+73.6%$230M$1.098.1%19.2%
2024$56M+313.1%$128M$0.645.6%12.8%
2023-$26M+41.0%$38M$-0.31-3.0%4.4%
2022-$44M-601.3%$41M$-0.53-5.9%5.4%
2021$9M-77.7%$80M$0.121.2%10.9%
2020$40M-46.3%$109M$0.587.5%20.5%
2019$74M+56.0%$78M$1.1725.7%27.0%
2018$47M+79.6%$54M$0.7720.6%23.7%
2017$26M+58.8%$41M$0.4414.8%23.1%
2016$17M+63.4%$26M$0.2813.1%20.6%
2015$10M+724.5%$17M$0.2111.6%19.2%
2014$1M-89.0%$12M$0.032.0%18.6%
2013$11M-$7M$0.2124.2%15.4%

Download Data

Export HQY earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

13+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

HQY — Frequently Asked Questions

Quick answers to the most common questions about buying HQY stock.

What is HQY earnings per share (EPS)?

HQY trailing twelve-month (TTM) diluted EPS is $2.71, reflecting +125.7% year-over-year growth. The 5-year EPS CAGR is +83.0%. Complete EPS history from 2013 to 2026 is available in the table on this page.

What is HealthEquity, Inc.'s net income?

HealthEquity, Inc. (HQY) trailing twelve-month net income is $231M as of 2026. Earnings grew +125.7% year-over-year. HealthEquity, Inc. has been profitable for 3 consecutive years.

Is HQY profitable?

Yes, HQY is profitable with a TTM net income of $231M and a net profit margin of +16.4%. HealthEquity, Inc. has generated profits for 3 consecutive years.

What is HQY's earnings growth rate?

HQY compound annual EPS growth rates (CAGR): 1-Year: +125.7%, 3-Year: N/A, 5-Year: +83.0%, 10-Year: +24.3%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2013 to 2026.

What are HQY's profit margins?

HealthEquity, Inc. net profit margin is +16.4%, operating margin is +24.6%, and gross margin is +69.5%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +10.2%.

Is HQY growing earnings?

Yes, HQY earnings are accelerating — EPS growth of +125.7% exceeds the 5-year CAGR of +83.0%. TTM net income reached $231M. Earnings momentum is strengthening.

What was HQY's best earnings year?

HealthEquity, Inc.'s highest annual net income on record is $215M, achieved in fiscal year 2026. Earnings history on this page spans 2013 to 2026 and includes all annual and quarterly figures.

What were HQY's earnings last quarter?

HQY's most recent reported quarter was Q1 2027. Net income was $69M with diluted EPS of $0.82. For a full breakdown of all quarters, see the quarterly earnings table on this page.

HQY Earnings Over Time (2013–2026)

Net income & EPS — annual and quarterly view